Journal of Muscle Research and Cell Motility

SJR Rank #8,922H-index: 73SJR: 0.656Best quartile: Q3APC: US$3,890
Journal website: aims, scope and author guidelines
Publisher

Springer Science and Business Media Deutschland GmbH

Country

Germany

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • BiochemistryQ3
  • Cell BiologyQ3
  • PhysiologyQ3

Areas: Biochemistry, Genetics and Molecular Biology

Most published research topics

Cardiomyopathy and Myosin StudiesMuscle Physiology and DisordersMuscle activation and electromyography studiesIon channel regulation and functionCardiovascular Effects of ExerciseCellular Mechanics and InteractionsForce Microscopy Techniques and ApplicationsMuscle metabolism and nutritionExercise and Physiological ResponsesAdipose Tissue and Metabolism

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs020406080

Documents per Year

2022202509182736

Detailed Information

ISSN

1573-2657, 0142-4319

SJR Best Quartile

Q3

Region

Western Europe

Citations per Document (2 years)

2.47

References per Document

67.53

Coverage

1963-1964, 1980-2026

Scope

The Journal of Muscle Research and Cell Motility has as its main aim the publication of original research which bears on either the excitation and contraction of muscle, the analysis of any one of the processes involved therein, the processes underlying contractility and motility of animal and plant cells, the toxicology and pharmacology related to contractility, or the formation, dynamics and turnover of contractile structures in muscle and non-muscle cells. Studies describing the impact of pathogenic mutations in genes encoding components of contractile structures in humans or animals are welcome, provided they offer mechanistic insight into the disease process or the underlying gene function. The policy of the Journal is to encourage any form of novel practical study whatever its specialist interest, as long as it falls within this broad field. Theoretical essays are welcome provided that they are concise and suggest practical ways in which they may be tested. Manuscripts reporting new mutations in known disease genes without validation and mechanistic insight will not be considered. It is the policy of the journal that cells lines, hybridomas and DNA clones should be made available by the developers to any qualified investigator. Submission of a manuscript for publication constitutes an agreement of the authors to abide by this principle.

Metrics from SCImago Journal Rank 2025. View on SCImago